An Efficacy and Safety Study of Luspatercept (ACE-536) Versus Placebo in Adults Who Require Regular Red Blood Cell Transfusions Due to Beta (β) Thalassemia
PHASE3
This is a Phase 3, double-blind, randomized, placebo-controlled, multicente...
Study of Pembrolizumab (MK-3475) or Placebo Given With Best Supportive Care in Asian Participants With Previously Treated Advanced Hepatocellular Carcinoma (MK-3475-394/KEYNOTE-394)
PHASE3
The purpose of this study is to determine the efficacy and safety of pembro...
Global Study Looking at the Combination of RAD001 Plus Best Supportive Care (BSC) and Placebo Plus BSC to Treat Patients With Advanced Hepatocellular Carcinoma.
PHASE3
The purpose of this study is to compare treatment with RAD001 plus best sup...
Status
Completed
Location
Highlands Oncology Group Dept of Highlands Oncology Grp